Asset Details
Do you wish to reserve the book?
Serology testing in the COVID-19 pandemic response
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Serology testing in the COVID-19 pandemic response
Do you wish to request the book?
Serology testing in the COVID-19 pandemic response
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Serology testing in the COVID-19 pandemic response
2020
Overview
The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Antibodies, Viral - metabolism
/ Antigens
/ Betacoronavirus - immunology
/ Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - immunology
/ Coronavirus Infections - prevention & control
/ Coronavirus Infections - transmission
/ COVID-19
/ Humans
/ Immunoglobulin G - metabolism
/ Immunoglobulin M - metabolism
/ Income
/ Pandemics - prevention & control
/ Pneumonia, Viral - diagnosis
/ Pneumonia, Viral - immunology
/ Pneumonia, Viral - prevention & control
/ Pneumonia, Viral - transmission
/ Proteins
/ R&D
/ Serology
